• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by U.S. Physical Therapy Inc.

    1/29/26 3:11:37 PM ET
    $USPH
    Medical/Nursing Services
    Health Care
    Get the next $USPH alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    U S PHYSICAL THERAPY INC /NV

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    90337L108

    (CUSIP Number)


    12/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    90337L108


    1Names of Reporting Persons

    Copeland Capital Management, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    512,506.00
    6Shared Voting Power

    126,549.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    786,114.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    786,114.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.17 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    U S PHYSICAL THERAPY INC /NV
    (b)Address of issuer's principal executive offices:

    1300 WEST SAM HOUSTON PARKWAY, SUITE 300, HOUSTON, TX, 77043
    Item 2. 
    (a)Name of person filing:

    Sofia A. Rosala
    (b)Address or principal business office or, if none, residence:

    161 Washington St, Suite 1325, Conshohocken, PA 19428
    (c)Citizenship:

    U.S.A
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    90337L108
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    786,1114
    (b)Percent of class:

    5.17%
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    512,506

     (ii) Shared power to vote or to direct the vote:

    126,549

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    786,114

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Copeland Capital Management, LLC
     
    Signature:/s/ Sofia A. Rosala
    Name/Title:General Counsel and CCO
    Date:01/28/2026
    Get the next $USPH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $USPH

    DatePrice TargetRatingAnalyst
    9/18/2025$110.00Overweight
    Analyst
    12/16/2024$100.00 → $115.00Neutral → Buy
    BofA Securities
    12/16/2024$113.00Mkt Outperform
    JMP Securities
    10/7/2024$114.00 → $90.00Buy → Neutral
    BofA Securities
    9/22/2023$108.00Overweight
    JP Morgan
    6/30/2023$138.00Buy
    BofA Securities
    12/14/2021$120.00Market Perform → Market Outperform
    CJS Securities
    8/6/2021$130.00 → $139.00Outperform
    Barrington Research
    More analyst ratings

    $USPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on U.S. Physical Therapy with a new price target

    Analyst resumed coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $110.00

    9/18/25 8:45:48 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy upgraded by BofA Securities with a new price target

    BofA Securities upgraded U.S. Physical Therapy from Neutral to Buy and set a new price target of $115.00 from $100.00 previously

    12/16/24 6:45:03 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    JMP Securities initiated coverage on U.S. Physical Therapy with a new price target

    JMP Securities initiated coverage of U.S. Physical Therapy with a rating of Mkt Outperform and set a new price target of $113.00

    12/16/24 6:39:42 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO Reeve Graham D. sold $52,760 worth of shares (743 units at $71.01), decreasing direct ownership by 3% to 20,740 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    11/25/25 4:08:03 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Director Gilmartin Kathleen A bought $276,000 worth of shares (4,000 units at $69.00), increasing direct ownership by 19% to 24,786 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    11/24/25 4:09:17 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Director Ham Nancy sold $49,026 worth of shares (600 units at $81.71), decreasing direct ownership by 23% to 1,994 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    9/11/25 4:51:38 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Financials

    Live finance-specific insights

    View All

    U.S. Physical Therapy Announces the Acquisition of an Eight-Clinic Physical Therapy Management Services Company

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy management services company, which exclusively manages a physical therapy practice with eight clinic locations, generating approximately $8.0 million in annual revenues and 66,000 in annual visits. USPH acquired a 50% interest and 50% was retained by the current owners. Graham Reeve, Chief Operating Officer-West, said, "We are excited to welcome our newest partners into the USPH family and expand our service offerings. This team delivers outstanding c

    1/5/26 7:30:00 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Reports Third Quarter 2025 Results

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and nine months ended September 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $23.9 million for the three months ended September 30, 2025 ("2025 Third Quarter"), an increase of $2.8 million, or 13.2%, from $21.1 million for the three months ended September 30, 2024 ("2024 Third Quarter") primarily driven by clinic additions. Net income attributable to USPH shareholders ("USPH Net Incom

    11/5/25 5:00:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call Dates

    U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three months and nine months ended September 30, 2025, on Wednesday, November 5, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, November 6, 2025. Conference Call   Date:   Thursday, November 6, 2025     Time:   10:30 am Eastern / 9:30 am Central     Dial-In Number:   (800) 245-3047 Primary or         (203) 518-9765 Alternate     Conference ID

    10/22/25 8:30:00 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by U.S. Physical Therapy Inc.

    SCHEDULE 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    1/29/26 3:11:37 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)

    1/7/26 4:05:17 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)

    11/18/25 4:09:52 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gilmartin Kathleen A bought $276,000 worth of shares (4,000 units at $69.00), increasing direct ownership by 19% to 24,786 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    11/24/25 4:09:17 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Director Gilmartin Kathleen A bought $172,180 worth of shares (2,000 units at $86.09), increasing direct ownership by 12% to 18,904 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    9/3/24 6:38:08 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Gilmartin Kathleen A bought $82,340 worth of shares (1,000 units at $82.34), increasing direct ownership by 7% to 15,480 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    11/13/23 7:09:28 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. Physical Therapy Presented at the J.P. Morgan 2026 Healthcare Conference

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 780 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured w

    1/15/26 7:30:00 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Announces the Acquisition of an Eight-Clinic Physical Therapy Management Services Company

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy management services company, which exclusively manages a physical therapy practice with eight clinic locations, generating approximately $8.0 million in annual revenues and 66,000 in annual visits. USPH acquired a 50% interest and 50% was retained by the current owners. Graham Reeve, Chief Operating Officer-West, said, "We are excited to welcome our newest partners into the USPH family and expand our service offerings. This team delivers outstanding c

    1/5/26 7:30:00 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Reports Third Quarter 2025 Results

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and nine months ended September 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $23.9 million for the three months ended September 30, 2025 ("2025 Third Quarter"), an increase of $2.8 million, or 13.2%, from $21.1 million for the three months ended September 30, 2024 ("2024 Third Quarter") primarily driven by clinic additions. Net income attributable to USPH shareholders ("USPH Net Incom

    11/5/25 5:00:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by U.S. Physical Therapy Inc.

    SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    11/13/24 4:05:19 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by U.S. Physical Therapy Inc.

    SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    10/22/24 3:57:52 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by U.S. Physical Therapy Inc.

    SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    2/14/24 10:04:34 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Leadership Updates

    Live Leadership Updates

    View All

    U.S. Physical Therapy Announces Dual Listing on NYSE Texas

    U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services headquartered in Houston, Texas, today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas, Texas. U.S. Physical Therapy will maintain its primary listing on the New York Stock Exchange and trade with the same "USPH" ticker symbol on NYSE Texas. Chris Reading, Chairman and Chief Executive Officer, said, "We are honored to join NYSE Texas as a Founding Member and to champion the dynamic growth, energy and grit that define this great state. Being

    5/28/25 4:10:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board

    EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue

    6/20/23 8:00:00 AM ET
    $POAI
    $RTX
    $USPH
    Industrial Specialties
    Health Care
    Aerospace
    Industrials

    National Kidney Foundation Appoints Anne Motsenbocker to Board of Directors

    ~Highly Esteemed Growth Strategist and Financial Expert with Decades of Business Acumen~ NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors. We're honored & excited Anne has joined the national board to share her extensive business acumen in board governance.Motsenbocker resides in Dallas, Texas and is a former banker and seasoned board member bringing over 35 years of commercial banking and wealth management expertise due to the numerous roles she held at J

    10/18/22 9:00:00 AM ET
    $CSWI
    $USPH
    Home Furnishings
    Industrials
    Medical/Nursing Services
    Health Care